Key role for myeloid cells: Phase II results of anti-GD2antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma-Reference-Cited by-同舟云学术

Key role for myeloid cells: Phase II results of anti-GD2antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma

Published:2014-04-03 Issue:9 Volume:135 Page:2199-2205
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Cheung Nai-Kong V.¹,Cheung Irene Y.¹,Kramer Kim¹,Modak Shakeel¹,Kuk Deborah²,Pandit-Taskar Neeta³,Chamberlain Elizabeth¹,Ostrovnaya Irina²,Kushner Brian H.¹

Affiliation:

1. Department of Pediatrics; Memorial Sloan-Kettering Cancer Center; New York NY

2. Department of Epidemiology and Biostatistics; Memorial Sloan-Kettering Cancer Center; New York NY

3. Department of Radiology; Memorial Sloan-Kettering Cancer Center; New York NY

Funder

National Cancer Institute, Bethesda, MD

Hope Street Kids, Alexandria, VA

Justin Zahn Fund, NY

Katie's Find A Cure Fund, NY

Robert Steel Foundation, NY

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.28851/fullpdf

Reference25 articles.

1. The prognostic impact of functional imaging with 123I-mIBG in patients with stage 4 neuroblastoma >1 year of age on a high-risk treatment protocol: results of the German Neuroblastoma Trial NB97;Schmidt;Eur J Cancer,2008

2. Comparison of 123I-metaiodobenzylguanidine (MIBG) and 131I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology Group;Naranjo;Pediatr Blood Cancer,2011

3. Biodistribution of post-therapeutic versus diagnostic 131I-MIBG scans in children with neuroblastoma;Hickeson;Pediatr Blood Cancer,2004

4. Radioimmunodetection of neuroblastoma with iodine-131-3F8: correlation with biopsy, iodine-131-metaiodobenzylguanidine and standard diagnostic modalities;Yeh;J Nucl Med,1991

5. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma;Yu;N Engl J Med,2010

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adolescent‐ and adult‐onset neuroblastic tumor: A retrospective multicenter observational study of patients diagnosed in France between 2000 and 2020;Pediatric Blood & Cancer;2024-05-22

2. Management of High-Risk Neuroblastoma with Soft-Tissue-Only Disease in the Era of Anti-GD2 Immunotherapy;Cancers;2024-04-29

3. GD2-targeting therapy: a comparative analysis of approaches and promising directions;Frontiers in Immunology;2024-03-15

4. Re-Engaging the Immune System: Immunotherapy for Neuroblastoma;Pediatric Oncology;2024

5. GM‐CSF, G‐CSF or no cytokine therapy with anti‐GD2 immunotherapy for high‐risk neuroblastoma;International Journal of Cancer;2023-12-18